12645 MEMORIAL DR., SUITE F1 #305, HOUSTON, TX
Announces Pricing of $20 Million Upsized Public Offering of Common Stock
Other Events
Reports Second Quarter Financial Results and Provides a Corporate Update
Shareholder votes
Annual Report to Security Holders
Reports First Quarter Financial Results and Provides a Corporate Update
Q2
Q1
Amended Annual Report
FY 2024
FY 2023
Q3
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Prospectus filed pursuant to Rule 424(b)(7)
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement
SEC Staff Correspondence